SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-117711
Filing Date
2016-05-04
Accepted
2016-05-04 16:32:22
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6647_110q.htm 10-Q 867631
2 EX-31.1 a16-6647_1ex31d1.htm EX-31.1 13902
3 EX-31.2 a16-6647_1ex31d2.htm EX-31.2 13411
4 EX-32.1 a16-6647_1ex32d1.htm EX-32.1 7069
5 EX-32.2 a16-6647_1ex32d2.htm EX-32.2 7051
  Complete submission text file 0001104659-16-117711.txt   3659993

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT loxo-20160331.xml EX-101.INS 795754
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20160331.xsd EX-101.SCH 27178
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20160331_cal.xml EX-101.CAL 28369
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20160331_def.xml EX-101.DEF 99497
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20160331_lab.xml EX-101.LAB 277671
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20160331_pre.xml EX-101.PRE 191301
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 161619885
SIC: 2834 Pharmaceutical Preparations